These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report. Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944 [TBL] [Abstract][Full Text] [Related]
27. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805 [TBL] [Abstract][Full Text] [Related]
28. Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release. Manotheepan R; Danielsen TK; Sadredini M; Anderson ME; Carlson CR; Lehnart SE; Sjaastad I; Stokke MK Cardiovasc Res; 2016 Aug; 111(3):295-306. PubMed ID: 27161030 [TBL] [Abstract][Full Text] [Related]
29. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model. Kobayashi S; Yano M; Uchinoumi H; Suetomi T; Susa T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Yamamoto T; Matsuzaki M Circ J; 2010 Nov; 74(12):2579-84. PubMed ID: 20944434 [TBL] [Abstract][Full Text] [Related]
30. Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia. Liu B; Walton SD; Ho HT; Belevych AE; Tikunova SB; Bonilla I; Shettigar V; Knollmann BC; Priori SG; Volpe P; Radwański PB; Davis JP; Györke S J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720499 [TBL] [Abstract][Full Text] [Related]
31. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167 [TBL] [Abstract][Full Text] [Related]
32. Post-Translational Modifications and Diastolic Calcium Leak Associated to the Novel RyR2-D3638A Mutation Lead to CPVT in Patient-Specific hiPSC-Derived Cardiomyocytes. Acimovic I; Refaat MM; Moreau A; Salykin A; Reiken S; Sleiman Y; Souidi M; Přibyl J; Kajava AV; Richard S; Lu JT; Chevalier P; Skládal P; Dvořak P; Rotrekl V; Marks AR; Scheinman MM; Lacampagne A; Meli AC J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30413023 [TBL] [Abstract][Full Text] [Related]
33. Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias. Xiao Z; Guo W; Sun B; Hunt DJ; Wei J; Liu Y; Wang Y; Wang R; Jones PP; Back TG; Chen SRW J Biol Chem; 2016 Nov; 291(47):24528-24537. PubMed ID: 27733687 [TBL] [Abstract][Full Text] [Related]
34. Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). Dulhunty AF Front Physiol; 2022; 13():830367. PubMed ID: 35222090 [TBL] [Abstract][Full Text] [Related]
35. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts. Tateishi H; Yano M; Mochizuki M; Suetomi T; Ono M; Xu X; Uchinoumi H; Okuda S; Oda T; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M Cardiovasc Res; 2009 Feb; 81(3):536-45. PubMed ID: 18996969 [TBL] [Abstract][Full Text] [Related]
36. Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca Ottesen AH; Carlson CR; Eken OS; Sadredini M; Myhre PL; Shen X; Dalhus B; Laver DR; Lunde PK; Kurola J; Lunde M; Hoff JE; Godang K; Sjaastad I; Pettilä V; Stridsberg M; Lehnart SE; Edwards AG; Lunde IG; Omland T; Stokke MK; Christensen G; Røsjø H; Louch WE Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e007045. PubMed ID: 30943765 [TBL] [Abstract][Full Text] [Related]
37. Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release. Søndergaard MT; Tian X; Liu Y; Wang R; Chazin WJ; Chen SR; Overgaard MT J Biol Chem; 2015 Oct; 290(43):26151-62. PubMed ID: 26309258 [TBL] [Abstract][Full Text] [Related]